Vicore Pharma Holding AB
STO:VICO

Watchlist Manager
Vicore Pharma Holding AB Logo
Vicore Pharma Holding AB
STO:VICO
Watchlist
Price: 7.91 SEK 1.67% Market Closed
Market Cap: 1.9B SEK
Have any thoughts about
Vicore Pharma Holding AB?
Write Note

Balance Sheet

Balance Sheet Decomposition
Vicore Pharma Holding AB

Current Assets 478.2m
Cash & Short-Term Investments 466.4m
Receivables 1.6m
Other Current Assets 10.1m
Non-Current Assets 565k
PP&E 10k
Intangibles 555k
Current Liabilities 39.9m
Accounts Payable 18.2m
Accrued Liabilities 17.1m
Other Current Liabilities 4.7m
Non-Current Liabilities 3.8m
Other Non-Current Liabilities 3.8m

Balance Sheet
Vicore Pharma Holding AB

Rotate your device to view
Balance Sheet
Currency: SEK
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
2
25
4
24
225
188
249
294
257
334
Cash
2
25
4
24
225
188
249
294
257
334
Short-Term Investments
0
0
0
0
0
77
70
77
5
149
Total Receivables
0
1
0
1
2
1
5
1
2
3
Accounts Receivables
0
0
0
0
0
0
0
0
0
0
Other Receivables
0
1
0
0
2
1
0
0
0
3
Other Current Assets
0
0
0
0
1
0
4
5
6
10
Total Current Assets
2
26
5
25
227
267
328
378
270
496
PP&E Net
0
0
0
0
0
0
0
0
0
0
PP&E Gross
0
0
0
0
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
0
0
0
0
Intangible Assets
37
43
17
17
69
68
71
67
68
2
Note Receivable
0
0
0
0
0
0
0
0
0
0
Long-Term Investments
20
20
16
23
6
6
8
5
0
0
Other Long-Term Assets
0
0
0
0
0
0
0
0
0
0
Total Assets
59
N/A
89
+50%
38
-58%
64
+70%
302
+370%
341
+13%
407
+19%
451
+11%
338
-25%
498
+47%
Liabilities
Accounts Payable
1
2
2
3
2
5
11
24
23
18
Accrued Liabilities
1
1
2
1
11
8
30
40
18
15
Short-Term Debt
0
0
0
0
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Other Current Liabilities
0
2
0
0
1
4
7
2
5
8
Total Current Liabilities
4
5
4
5
14
17
48
66
46
41
Long-Term Debt
0
0
0
0
0
0
0
0
0
0
Deferred Income Tax
2
2
2
2
2
2
2
1
1
1
Other Liabilities
0
0
0
0
0
1
2
1
2
1
Total Liabilities
6
N/A
7
+29%
6
-17%
7
+8%
16
+146%
20
+21%
52
+167%
68
+30%
49
-28%
42
-13%
Equity
Common Stock
3
6
6
8
21
25
30
36
41
56
Retained Earnings
4
1
51
75
138
231
378
674
963
1 274
Other Equity
46
76
77
125
402
527
702
1 022
1 211
1 674
Total Equity
54
N/A
82
+53%
32
-61%
58
+82%
285
+396%
322
+13%
355
+10%
383
+8%
289
-25%
455
+58%
Total Liabilities & Equity
59
N/A
89
+50%
38
-58%
64
+70%
302
+370%
341
+13%
407
+19%
451
+11%
338
-25%
498
+47%
Shares Outstanding
Common Shares Outstanding
8
14
14
18
33
50
60
74
84
115

See Also

Discover More